← Back to headlines
New Study Shows Sustained Weight Loss with Eli Lilly Pill
A new study has revealed that a pill developed by Eli Lilly, a competitor to Novo Nordisk, can lead to sustained weight loss. This research highlights the potential for a new pharmaceutical option in weight management.
Sources
Showing 0 of 2 sources
No articles available in your preferred languages.
2 articles available in other languages below.
dr-dkDanish2h ago
Nyt studie viser varigt vægttab ved indtagelse af pille fra Novo-konkurrent
Read full article →berlingskeDanish2h ago
Nyt studie viser varigt vægttab ved indtagelse af Eli Lilly-pille
Det er en kendt risiko, at personer, der har fået behandling med vægttabsmedicin, ender med at tage på igen.
Read full article →Coverage Timeline
First report: berlingske · 13 May, 02:03|Full coverage: 2 · 6m|Window: 6m
Left-leaningCenterRight-leaning
